The Short Answer
Frozen embryo transfer (FET) has become the dominant approach in modern IVF — and for most patients, it produces better outcomes than a fresh transfer. In a fresh cycle, the embryo is transferred in the same cycle as egg retrieval, while your ovaries are still recovering from stimulation hormones. In a FET, all embryos are frozen after retrieval, and the transfer happens in a separate cycle a month or two later, when the uterus has had time to normalize. A large body of evidence now shows that in many patient populations, FET produces higher live birth rates and lower complication rates. But it is not universally better for everyone, and some situations still favor a fresh approach.
Why has frozen embryo transfer become the standard?
The shift toward FET accelerated once vitrification (ultra-rapid flash-freezing) became standard in embryology labs around 2012 — the ASRM has a patient guide on frozen transfers. Before vitrification, frozen embryo survival rates were lower and fresh transfers had a natural advantage. Now that frozen embryo survival exceeds 90–95%, the question shifted from "can frozen embryos survive?" to "which uterine environment is better?"
The answer, for most patients, is the FET environment. Here is why: ovarian stimulation raises estrogen to many times its natural level. This elevated estrogen affects the endometrium (uterine lining) in ways that may impair implantation. A fresh transfer asks the embryo to implant in a uterus still under the influence of those stimulation hormones. An FET cycle allows the ovaries to fully recover, hormones to normalize, and the endometrium to be prepared freshly on a controlled protocol — progesterone only, without the superphysiological estrogen spikes of a stimulation cycle.
What does the research say about FET vs. fresh success rates?
Multiple large randomized controlled trials and meta-analyses have compared the two approaches. The picture is nuanced:
- For patients with normal ovarian response, several large trials (including the FRESH trial and POSEIDON data) show comparable live birth rates between fresh and FET. The advantage of FET is primarily seen in specific subgroups.
- For patients with high ovarian response (many eggs retrieved, high estrogen levels), FET is clearly superior. These patients are most at risk for ovarian hyperstimulation syndrome (OHSS) and have the most disrupted endometrial environment — both reasons to freeze all and transfer later.
- For patients doing PGT-A genetic testing, FET is required regardless, since embryos must be biopsied, frozen, and tested before transfer.
- For patients with thin endometrial lining during a stimulation cycle, FET allows a fresh attempt at lining preparation without the compounding effects of the retrieval cycle.
According to CDC ART data, national live birth rates from FET cycles have now surpassed fresh transfer cycles in aggregate — partly reflecting better patient selection and partly the genuine advantage of the controlled FET environment for many patients.
What are the advantages of a fresh embryo transfer?
Fresh transfers still have real advantages in certain situations:
- Speed: One fewer cycle means one fewer month of waiting, which matters for patients with limited time or emotional reserves for a longer process.
- Cost: FET adds a full additional cycle's cost — monitoring, medications (progesterone, estradiol), and sometimes a mock cycle beforehand. This can add $3,000–$5,000 to the total bill.
- Good prognosis patients with normal response: For women under 35 with normal ovarian response, good embryo quality, and a well-developed lining during the stimulation cycle, fresh transfer outcomes are often equivalent to FET. There is no need to add complexity and cost without clinical reason.
- No freeze risk: Though vitrification survival is excellent, there is still a small theoretical risk (essentially negligible with good labs) associated with freezing and thawing. For patients with very few eggs and embryos, some clinicians prefer not to add any risk from the freeze-thaw cycle.
What is a freeze-all cycle?
A "freeze-all" cycle is exactly what it sounds like: all usable embryos from a retrieval are frozen, with no fresh transfer attempted in that retrieval cycle. The patient then returns for a FET in a subsequent cycle. This approach is now recommended by most IVF programs for patients doing PGT-A, patients with high ovarian response or OHSS risk, patients with thin lining, and patients taking medications that might affect receptivity. For many programs, freeze-all has become the default rather than the exception.
What does a frozen embryo transfer cycle involve?
An FET cycle is typically simpler than a retrieval cycle — no injections for weeks, no egg retrieval. The most common protocol:
- Estradiol priming (2–4 weeks): Oral or patch-delivered estradiol builds the uterine lining to the target thickness (ideally 7mm or more).
- Lining check: Ultrasound confirms lining thickness and appearance (trilaminar pattern is ideal).
- Progesterone start: Progesterone (suppositories, injections, or gel) begins 5 days before a day-5 embryo transfer, or 3 days before for a day-3 embryo. Timing is precise.
- Transfer: Same simple procedure as a fresh transfer — thin catheter, full bladder, 10 minutes.
- Luteal support: Progesterone continues for 10–12 weeks if pregnancy is confirmed.
Natural-cycle FETs (using your own natural ovulation to time transfer, rather than medication control) are also used at some clinics for patients with regular cycles. Evidence shows similar outcomes to medicated FETs in appropriate patients, with lower medication costs and burden.
How long does a frozen embryo transfer take from retrieval?
Typically 4–8 weeks after retrieval, depending on your clinic's protocol and cycle timing. If you are doing PGT-A, add the genetic testing turnaround (7–10 days) plus waiting for the right cycle day to start FET preparation. From retrieval to a FET pregnancy test, plan for 2–3 months in most cases.
Does FET increase the risk of complications?
One area where FET data is mixed: some large studies have found slightly higher rates of placenta previa and large-for-gestational-age (LGA) babies in FET pregnancies compared to fresh transfers. The reasons are not fully understood. These risks are still low in absolute terms, but they are real findings that your OB should be aware of if you conceive via FET. The ongoing discussion in reproductive medicine is whether the FET endometrial environment (high progesterone, no natural ovulation) alters placentation in subtle ways. Research is active.
Should I ask for a fresh or frozen transfer?
That decision should be driven by your clinical picture, not preference. Tell your doctor your priorities (speed, cost, outcomes) and ask them to walk you through the reasoning for their recommendation based on your ovarian reserve, response, lining development, and risk factors. If your clinic defaults to freeze-all without clinical explanation for your specific situation, it is reasonable to ask why. If they recommend fresh despite a high estrogen level or OHSS signs, that is also worth questioning.
Find a Clinic With a Strong FET Program
Lab quality matters for frozen cycles — the embryo's survival through the freeze-thaw process depends on the embryologist's skill and equipment. When comparing clinics, ask specifically about their embryo survival rate after vitrification (above 95% is the benchmark at top labs). Browse our directory of 524 fertility clinics to compare CDC outcomes data, or use our free matching tool.